The global Irritable Bowel Syndrome Treatment Market is divided into three segments: type, product, and distribution channel. The market is divided into three types: mixed IBS (IBS-M), IBS with diarrhoea (IBS-D), and IBS with constipation (IBS-C) (IBS-C). The mixed IBS (IBS-M) segment held the largest market share in 2020 and is expected to grow at the fastest rate between 2021 and 2028. Based on product, the irritable bowel syndrome (IBS) therapy market is divided into rifaximin, eluxadoline, lubiprostone, linaclotide, and others. In 2020, the linaclotide segment retained the greatest market share.x
Read More:
https://knackersblogger.blogspot.com/2022/10/growing-prevalence-of-irritable-bowel.html
Click here for Irritable Bowel Syndrome Treatment Market Press Release
